
Arstasis raises $38 million for vascular access devices
Redwood City, Calif.-based Arstasis Inc. raised $37.8 million of a hoped-for $51.2 million funding round among 14 unnamed investors.
The privately owned device maker develops vascular access devices designed for arterial closure in catheterization procedures, and says its strength is derived from engineering expertise, hard work and a "get ‘er done" attitude.
Arstasis won FDA 510(k) clearance in May 2010 for its Arstasisone femoral artery access system, which the company claimed was "the beginning of a potential new standard of care for angiographic procedures." The device represented the 1st system in 51 years to stray from the "modified seldinger technique" for accessing a patient’s arterial-vascular system.
Read more
Startup MxBiodevices lands $30k inception loan
Newly formed MxBiodevices won a $30,000 "company inception loan" from the North Carolina Biotechnology Center. The company is " preparing to commercialize the most advanced wound healing product for diabetic foot ulcers in the world," according to its website.
Read more
Joint repair devices maker lands $12M
Joint repair devices maker Biomimedica raised $11.8 million of a hoped-for $14.1 million funding round among 10 unnamed investors. The San Francisco-based company develops synthetic cartilage for use in early intervention solutions to treat osteoarthritis.
Read more